Your browser is no longer supported. Please, upgrade your browser.
OPTN OptiNose, Inc. daily Stock Chart
OPTN [NASD]
OptiNose, Inc.
Index- P/E- EPS (ttm)-2.63 Insider Own0.10% Shs Outstand47.75M Perf Week8.99%
Market Cap191.00M Forward P/E- EPS next Y-1.10 Insider Trans-98.42% Shs Float23.03M Perf Month-37.98%
Income-110.10M PEG- EPS next Q-0.67 Inst Own- Short Float32.21% Perf Quarter-59.76%
Sales34.60M P/S5.52 EPS this Y2.00% Inst Trans9.13% Short Ratio31.31 Perf Half Y-47.33%
Book/sh1.42 P/B2.82 EPS next Y50.70% ROA-64.60% Target Price20.17 Perf Year-59.27%
Cash/sh3.08 P/C1.30 EPS next 5Y- ROE-164.90% 52W Range3.28 - 11.66 Perf YTD-56.62%
Dividend- P/FCF- EPS past 5Y- ROI-75.50% 52W High-65.69% Beta-
Dividend %- Quick Ratio4.60 Sales past 5Y- Gross Margin84.70% 52W Low21.95% ATR0.54
Employees102 Current Ratio4.70 Sales Q/Q270.00% Oper. Margin- RSI (14)36.38 Volatility9.87% 11.85%
OptionableNo Debt/Eq1.21 EPS Q/Q10.10% Profit Margin- Rel Volume0.92 Prev Close4.16
ShortableYes LT Debt/Eq1.21 EarningsMar 05 BMO Payout- Avg Volume236.97K Price4.00
Recom1.80 SMA20-16.24% SMA50-39.40% SMA200-45.74% Volume219,187 Change-3.85%
Dec-18-19Initiated Cowen Outperform $25
Aug-08-18Initiated Cantor Fitzgerald Overweight
Mar-16-20 09:15AM  Moving Average Crossover Alert: OptiNose Zacks -20.25%
Mar-05-20 07:45AM  OptiNose (OPTN) Reports Q4 Loss, Misses Revenue Estimates Zacks -8.10%
06:30AM  Optinose Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Operational Highlights GlobeNewswire
Feb-27-20 04:30PM  Optinose to Report Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates on March 5, 2020 GlobeNewswire
Feb-26-20 12:30PM  Earnings Preview: OptiNose (OPTN) Q4 Earnings Expected to Decline Zacks
Feb-19-20 07:00AM  Optinose Appoints Victor Clavelli as Chief Commercial Officer GlobeNewswire
Dec-17-19 07:03PM  Hedge Funds Have Never Been This Bullish On OptiNose, Inc. (OPTN) Insider Monkey -5.02%
08:30AM  Optinose Announces Peer-Reviewed Publication of the Fourth Major XHANCE Registration Trial GlobeNewswire
Dec-10-19 12:12PM  Read This Before Selling OptiNose, Inc. (NASDAQ:OPTN) Shares Simply Wall St. +8.28%
Nov-26-19 04:01PM  Optinose to Present at the Piper Jaffray 31st Annual Healthcare Conference GlobeNewswire
Nov-21-19 09:00AM  Optinose Announces Pricing of Public Offering of Common Stock GlobeNewswire -17.62%
Nov-20-19 04:00PM  Optinose Announces Proposed Public Offering of Common Stock GlobeNewswire +7.74%
Nov-17-19 08:00AM  How health startup Optinose engineered a 300%+ spike in growth Yahoo Finance
Nov-12-19 04:01PM  Optinose Reports Third Quarter 2019 Financial Results and Recent Operational Highlights GlobeNewswire -6.09%
Nov-07-19 06:02PM  Hedge Funds Have Never Been More Bullish On OptiNose, Inc. (OPTN) Insider Monkey +5.85%
Nov-05-19 10:33AM  Earnings Preview: OptiNose (OPTN) Q3 Earnings Expected to Decline Zacks
Nov-01-19 08:00AM  Optinose to Report Third Quarter 2019 Financial Results and Corporate Updates on November 12, 2019 GlobeNewswire +8.95%
Oct-04-19 08:00AM  Optinose Appoints Michael Richardson to New Position of Vice President, Business Development Globenewswire Test
08:00AM  Optinose Appoints Michael Richardson to New Position of Vice President, Business Development GlobeNewswire
Sep-27-19 08:00AM  Optinose to Present at the 2019 Cantor Global Healthcare Conference GlobeNewswire
Sep-26-19 08:15AM  Currax Pharmaceuticals LLC Announces First Acquisition: Acquires North American Rights to ONZETRA® Xsail® PR Newswire
07:00AM  OptiNose Announces License Agreement Related to ONZETRA XSAIL GlobeNewswire
Sep-17-19 04:01PM  Optinose Announces Departure of Chief Commercial Officer GlobeNewswire +7.44%
Sep-12-19 04:05PM  Optinose Announces $150 Million Debt Financing from Pharmakon GlobeNewswire
Sep-11-19 01:34PM  Is OptiNose (NASDAQ:OPTN) Using Debt In A Risky Way? Simply Wall St.
Aug-13-19 03:45PM  OptiNose's Q2 Results Reflect Strong Underlying Trends, RBC Says Benzinga +11.59%
Aug-12-19 10:23PM  OptiNose, Inc. (OPTN) Q2 2019 Earnings Call Transcript Motley Fool +8.30%
05:25PM  OptiNose (OPTN) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:02PM  Optinose Reports Second Quarter 2019 Financial Results and Recent Operational Highlights GlobeNewswire
02:30PM  OptiNose, Inc. to Host Earnings Call ACCESSWIRE
Aug-05-19 10:30AM  Analysts Estimate OptiNose (OPTN) to Report a Decline in Earnings: What to Look Out for Zacks -5.19%
Aug-01-19 04:30PM  Optinose to Report Second Quarter 2019 Financial Results and Corporate Updates on August 12, 2019 GlobeNewswire
Jul-11-19 12:13PM  Those Who Purchased OptiNose (NASDAQ:OPTN) Shares A Year Ago Have A 73% Loss To Show For It Simply Wall St.
Jun-20-19 08:00AM  Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference GlobeNewswire +8.54%
Jun-19-19 04:30PM  Optinose Named a 2019 Best Place to Work by Philadelphia Business Journal GlobeNewswire +5.22%
May-22-19 10:42AM  You Can Get Buy Signals From Short Selling InvestorPlace
May-09-19 11:23AM  OptiNose, Inc. (OPTN) Q1 2019 Earnings Call Transcript Motley Fool -14.27%
08:55AM  OptiNose (OPTN) Reports Q1 Loss, Tops Revenue Estimates Zacks
07:46AM  OptiNose: 1Q Earnings Snapshot Associated Press
07:00AM  Optinose Reports First Quarter 2019 Financial Results and Recent Operational Highlights GlobeNewswire
May-02-19 10:33AM  OptiNose (OPTN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Apr-27-19 09:01AM  Have Insiders Been Buying OptiNose, Inc. (NASDAQ:OPTN) Shares? Simply Wall St.
Apr-25-19 07:00AM  Optinose to Report First Quarter 2019 Financial Results and Corporate Updates on May 9, 2019 GlobeNewswire
Mar-21-19 11:06AM  OptiNose Analysts Projects Prescription Growth In 2019, Beyond Benzinga
Mar-06-19 12:22PM  OptiNose, Inc. (OPTN) Q4 2018 Earnings Conference Call Transcript Motley Fool -5.76%
07:00AM  Optinose Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Operational Highlights GlobeNewswire
Feb-27-19 07:00AM  Optinose to Report Fourth Quarter 2018 Financial Results and Corporate Updates on March 6, 2019 GlobeNewswire
Feb-19-19 07:00AM  Optinose Announces Issuance of Four Additional U.S. Patents Covering XHANCE GlobeNewswire
Feb-15-19 07:00AM  Optinose to Highlight Data at the 2019 AAAAI Annual Meeting in San Francisco GlobeNewswire
Feb-04-19 12:46PM  Bucks County drug-device developer inks licensing deal worth a potential $45M American City Business Journals +6.36%
07:00AM  Optinose Announces License Agreement GlobeNewswire
Dec-25-18 10:28AM  OptiNose, Inc. (NASDAQ:OPTN): Time For A Financial Health Check Simply Wall St.
Dec-13-18 07:56AM  The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen Benzinga +8.99%
Dec-11-18 07:50AM  Investor Expectations to Drive Momentum within eBay, Pulse Biosciences, Evolus, Weibo, OptiNose, and The Descartes Systems Group Discovering Underlying Factors of Influence GlobeNewswire
07:00AM  Optinose Announces Update to License Agreement with Avanir Pharmaceuticals for ONZETRA XSAIL GlobeNewswire
Dec-10-18 07:00AM  Optinose Announces First Patient Enrolled in Clinical Trial of XHANCE for Chronic Sinusitis GlobeNewswire
Dec-05-18 04:30PM  Optinose to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference GlobeNewswire
Nov-26-18 05:29PM  Is OptiNose, Inc. (NASDAQ:OPTN) A Good Stock To Buy? Insider Monkey -5.49%
Nov-13-18 10:15AM  OptiNose (OPTN) Reports Q3 Loss, Tops Revenue Estimates Zacks +8.88%
09:11AM  OptiNose: 3Q Earnings Snapshot Associated Press
07:00AM  Optinose Reports Third Quarter 2018 Financial Results and Recent Operational Highlights GlobeNewswire
Oct-31-18 04:30PM  Optinose to Report Third Quarter 2018 Financial Results and Corporate Updates on November 13, 2018 GlobeNewswire
Oct-22-18 08:10AM  Detailed Research: Economic Perspectives on Caseys General Stores, Evolus, OptiNose, Xunlei, Molina Healthcare, and Frontline What Drives Growth in Today's Competitive Landscape GlobeNewswire
Oct-03-18 07:00AM  Optinose to Highlight Data at Two Upcoming Scientific Meetings GlobeNewswire
Sep-24-18 04:30PM  Optinose to Present at the 2018 Cantor Global Healthcare Conference GlobeNewswire
Aug-14-18 08:28PM  INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against OptiNose, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire -28.97%
12:48PM  INVESTOR ALERT: Investigation of OptiNose Announced by Holzer & Holzer Business Wire
12:40PM  The Probable Reason Behind OptiNose, Inc.'s Plunge Today Motley Fool
07:26AM  OptiNose: 2Q Earnings Snapshot Associated Press
07:00AM  Optinose Reports Second Quarter 2018 Financial Results and Recent Operational Highlights GlobeNewswire
06:00AM  OptiNose, Inc. to Host Earnings Call ACCESSWIRE
Aug-07-18 05:00PM  Optinose to Report Second Quarter 2018 Financial Results and Corporate Updates on August 14, 2018 GlobeNewswire
Jul-02-18 05:11PM  Optinose Named a 2018 Best Place to Work by Philadelphia Business Journal GlobeNewswire
Jun-21-18 04:30PM  Optinose Announces Publication of Pivotal Efficacy and Long-Term Safety Data for XHANCE in Peer Reviewed Journals GlobeNewswire
Jun-20-18 09:39AM  Mixed Signals on OptiNose Results In an Unappealing Risk/Reward Set-Up TheStreet.com
Jun-19-18 07:07PM  Cramer Remix: Go ahead, Chinasell your U.S. Treasurys! CNBC Videos
07:00PM  Medical device maker Optinose's CEO touts 'innovative' ap... CNBC Videos
Jun-15-18 02:05PM  Optinose CEO Peter Miller and President and COO Ramy Mahmoud Named EY Life Sciences Entrepreneur Of The Year 2018 in Greater GlobeNewswire +5.49%
Jun-12-18 12:10PM  Optinose completes $60M stock sale American City Business Journals
Jun-11-18 04:25PM  Optinose Announces Closing of Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Common Shares GlobeNewswire
Jun-07-18 01:16PM  Optinose seeking $52.3M from stock sale American City Business Journals
Jun-06-18 08:21PM  Optinose Announces Pricing of Public Offering of Common Stock GlobeNewswire
Jun-04-18 04:56PM  Optinose Announces Launch of Public Offering of Common Stock GlobeNewswire
May-23-18 07:40AM  Blog Exposure - Fibrocell Presented Update on Interim Results and Progress of its Phase-1/2 Clinical Trial of FCX-007 at International Investigative Dermatology Meeting ACCESSWIRE
May-14-18 08:35AM  What Should Investors Know About OptiNose Incs (NASDAQ:OPTN) Future? Simply Wall St. +10.18%
07:15AM  OptiNose: 1Q Earnings Snapshot Associated Press
07:00AM  Optinose Reports First Quarter 2018 Financial Results and Recent Operational Highlights GlobeNewswire
06:00AM  OptiNose, Inc. to Host Earnings Call ACCESSWIRE
May-07-18 08:00AM  Optinose to Report First Quarter 2018 Financial Results and Corporate Updates on May 14, 2018 GlobeNewswire
Apr-23-18 04:01PM  Optinose CEO Peter Miller and President/COO Ramy Mahmoud Named EY Entrepreneur of the Year 2018 Finalists in the Greater Philadelphia Area GlobeNewswire
Mar-16-18 03:32PM  Award time: Life Sciences Pennsylvania hands out annual industry awards American City Business Journals
Mar-15-18 04:01PM  Optinose Named Emerging Company of the Year by Life Sciences Pennsylvania GlobeNewswire
Mar-13-18 07:41AM  OptiNose reports 4Q loss Associated Press
07:00AM  Optinose Reports Fourth Quarter and Full Year 2017 Financial Results and Recent Operational Highlights GlobeNewswire
Mar-06-18 04:01PM  Optinose to Report Fourth Quarter and Full Year 2017 Financial Results and Corporate Updates on March 13, 2018 GlobeNewswire
Feb-27-18 07:00AM  Optinose to Highlight Data at the 2018 AAAAI/WAO Joint Congress GlobeNewswire
Feb-22-18 04:01PM  Optinose names Sandra L. Helton as Director and Chairperson of the Companys Audit Committee GlobeNewswire
Feb-20-18 04:01PM  Peter Miller Named Frank Baldino Bioscience CEO of the Year by Life Sciences Pennsylvania GlobeNewswire
Feb-15-18 08:00AM  Optinose to Present at the 2018 RBC Capital Markets Healthcare Conference GlobeNewswire
Feb-09-18 08:00AM  Optinose to Present at Leerink Partners 7th Annual Global Healthcare Conference GlobeNewswire
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, and throat; and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary optinose exhalation delivery system that delivers a topically-acting and anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps. It also markets Onzetra Xsail (AVP-825) for the acute treatment of migraines in adults through its license agreement with Avanir Pharmaceuticals, Inc. In addition, the company is developing XHANCE for the treatment of chronic sinusitis; and OPN-300 for the treatment of Prader-Willi syndrome, a rare genetic obesity disorder, as well as autism spectrum disorder. It has a license agreement with Inexia Limited to manufacture, import, and sale products containing orexin receptor agonist and/or orexin receptor positive modulator molecules for the treatment, diagnosis, or prevention of human diseases or conditions associated primarily with orexin receptor agonism and orexin receptor positive modulation. OptiNose, Inc. was founded in 2010 and is headquartered in Yardley, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
O'Neil Robert PDirectorMar 09Buy5.325,00026,5967,000Mar 09 04:33 PM
Scodari Joseph CDirectorMar 06Buy5.708,70049,60521,230Mar 09 07:07 AM
Scodari Joseph CDirectorDec 06Buy8.226,10050,14212,530Dec 09 02:42 PM
Avista Capital Partners II GP,10% OwnerNov 25Sale9.171,250,00011,456,250807,995Nov 26 05:41 PM
Venkataraman SriramDirectorNov 25Sale9.171,250,00011,456,250807,995Nov 26 05:36 PM